Monster Beverage (MNST) is having an ugly day. The beverage company��s share price fell almost 4% after Wells Fargo downgraded the stock to market perform�from outperform in anticipation of a weak second quarter.
As analyst Bonnie Herzog writes:
MNST has done an exceptional job of driving growth and margin expansion, which we expect to largely continue for the foreseeable future. However, we think near-term upside potential is more limited based on: (1) soft Q2 U.S. results; (2) delays in launching new innovation (now Q4 vs Q3); and (3) ongoing macro challenges in int’l markets. While we think downside risk is limited, we don’t see much near-term upside either given potential for Q2 EPS miss and thus would not add new money to MNST stock. Lower Q2 EPS $0.06 to $1.00 (vs. consensus of $1.04), and FY16/17 EPS $0.11/$0.10 to $3.98/$4.84 to reflect the above.
Best Healthcare Technology Companies To Invest In 2017: Coffee Holding Co., Inc.(JVA)
Advisors' Opinion: - [By Peter Graham]
A long term performance chart for Farmer Brothers Co shows an outstanding outperformance while large cap�Starbucks Corporation has been flat for more than a year and both iPath Bloomberg Coffee Subindex Total Return SM Index ETN and small cap Coffee Holding Co, Inc (NASDAQ: JVA) have underperformed:
Best Healthcare Technology Companies To Invest In 2017: Opexa Therapeutics, Inc.(OPXA)
Advisors' Opinion: Best Healthcare Technology Companies To Invest In 2017: CytRx Corporation(CYTR)
Advisors' Opinion: - [By Roberto Pedone]
Another under-$10 biotechnology player that's starting to trend within range of triggering a major breakout trade is CytRx (CYTR), which has an oncology pipeline that includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene. This stock has been moving to the upside during the last three months, with shares up by 21%.
If you take a look at the chart for CytRx, you'll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $2.27 on the downside and $2.68 on the upside. That consolidation pattern has occurred right above this stock's 50-day and 200-day moving averages. Shares of CYTR have now started to break out above some near-term overhead resistance at $2.49 a share. That move is quickly pushing CYTR within range of triggering an even bigger breakout trade above the upper-end of its recent sideways trading chart pattern.
Market players should now look for long-biased trades in CYTR if it manages to break out above some near-term overhead resistance levels at $2.68 to $2.80 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 154,838 shares. If that breakout triggers soon, then CYTR will set up to re-test or possibly take out its next major overhead resistance levels at $3.20 to $4 a share.
Traders can look to buy CYTR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day at $2.33 a share or below more support at $2.27 a share. One can also buy CYTR off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Best Healthcare Technology Companies To Invest In 2017: Moneygram International, Inc.(MGI)
Advisors' Opinion: - [By Jim Robertson]
On Friday, our Under the Radar Movers�newsletter suggested shorting small cap�money transfer services stock Moneygram International (NASDAQ: MGI):
- [By Lisa Levin]
Moneygram International Inc (NASDAQ: MGI) shares were also up, gaining 21 percent to $5.74 after the company reported upbeat Q4 earnings.
Equities Trading DOWN
Best Healthcare Technology Companies To Invest In 2017: Home Depot, Inc. (The)(HD)
Advisors' Opinion: - [By Ben Levisohn]
We wondered if Advance Auto Parts (AAP) just had a bad quarter or something more serious, whether there was beauty in being boring for Home Depot (HD), and just how risky Ford Motors’ (F) autonomous driving plan might be.
- [By WWW.THESTREET.COM]
Position: Long GLD small, bonds, SDS; short TLT small, SPY small . - [By Money Morning Staff Reports]
These dismal figures — exacerbated by the store's bidding war loss to acquire Home Depot Inc. (NYSE: HD) on May 8 — have many analysts now wondering, "will Staples go bankrupt in 2017?"
